Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Ming Tu

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Cancers|February 10, 2021
Curing Cancer: Lessons from a PrototypeShi-Ming Tu, Louis L Pisters
The Canadian Journal of Urology|June 19, 2012
Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesShi-Ming Tu, Adrienne H Chen
Clinical Case Reports|December 3, 2019
Rapidly enlarging abdominal mass in a patient with recurrent germ cell tumorLauren Ho, Louis Pisters, Shi-Ming Tu
Cancer|January 28, 2003
Targeting prostate cancer bone metastasesChristopher Logothetis, Shi-Ming Tu, Nora Navone
Clinical Genitourinary Cancer|July 16, 2013
Stem cell origin of testicular seminomaAvik Som, Sijin Wen, Shi-Ming Tu
Clinical Genitourinary Cancer|October 4, 2016
Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case ReportPavlos Msaouel, Miao Zhang, Shi-Ming Tu
Clinical Genitourinary Cancer|July 7, 2011
Prolonged remission of fulminant castrate-resistant prostate cancer: a case reportMehmet Asim Bilen, Rosale General, Shi-Ming Tu
Journal of the National Cancer Institute|August 7, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaShi-Ming Tu, Sue-Hwa Lin, Christopher Logothetis
Oncology (Williston Park, N.Y.)|July 17, 2015
Radium-223: Optimizing Treatment and Research of Osteoblastic Bone MetastasisShi-Ming Tu, Mehmet Asim Bilen, Sue-Hwa Lin
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Cancers|February 10, 2021
Curing Cancer: Lessons from a PrototypeShi-Ming Tu, Louis L Pisters
The Canadian Journal of Urology|June 19, 2012
Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastasesShi-Ming Tu, Adrienne H Chen
Clinical Case Reports|December 3, 2019
Rapidly enlarging abdominal mass in a patient with recurrent germ cell tumorLauren Ho, Louis Pisters, Shi-Ming Tu
Cancer|January 28, 2003
Targeting prostate cancer bone metastasesChristopher Logothetis, Shi-Ming Tu, Nora Navone
Clinical Genitourinary Cancer|July 16, 2013
Stem cell origin of testicular seminomaAvik Som, Sijin Wen, Shi-Ming Tu
Clinical Genitourinary Cancer|October 4, 2016
Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case ReportPavlos Msaouel, Miao Zhang, Shi-Ming Tu
Clinical Genitourinary Cancer|July 7, 2011
Prolonged remission of fulminant castrate-resistant prostate cancer: a case reportMehmet Asim Bilen, Rosale General, Shi-Ming Tu
Journal of the National Cancer Institute|August 7, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaShi-Ming Tu, Sue-Hwa Lin, Christopher Logothetis
Oncology (Williston Park, N.Y.)|July 17, 2015
Radium-223: Optimizing Treatment and Research of Osteoblastic Bone MetastasisShi-Ming Tu, Mehmet Asim Bilen, Sue-Hwa Lin
The Lancet. Oncology|July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumoursShi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Pageof 14